Targeting PIKfyve-driven lipid metabolism in pancreatic cancerCaleb Cheng, Arul M. Chinnaiyan, Ke Ding et al.|Nature|2025Cited by 37
Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyveChungen Li, Ke Ding, Yuzhuo Wang et al.|Journal of Medicinal Chemistry|2023Cited by 18
Structure-Based Design of “Head-to-Tail” Macrocyclic PROTACsChungen Li, Ke Ding|JACS Au|2024Cited by 16
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Arul M. Chinnaiyan, Yuanyuan Qiao et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 5
Abstract 2898: Development of the lipid kinase PIKfyve PROTAC degrader against neuroendocrine prostate cancerYuanyuan Qiao, Arul M. Chinnaiyan, Ke Ding et al.|Cancer Research|2024Cited by 0